Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: Effect of lazaroid therapy

Kidney International

Volumn 52, Issue 4, 1997, Pages 1042-1046

  Vaziri, Nosratola D ^a,b   Ding, Yaoxian ^a   Ni, Zhenmin ^a   Gonick, Harvey C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidants; Blood pressure; Endothelium derived relaxing factor; Heavy metals; Lipid peroxidation; Reactive oxygen species

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; ENDOTHELIUM DERIVED RELAXING FACTOR; LAZAROID; LEAD; MALONALDEHYDE; NITRIC OXIDE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; TIRILAZAD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; DRUG INDUCED DISEASE; HYPERTENSION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; URINARY EXCRETION;

EID: 0030842707     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.426     Document Type: Article

References (29)

1. SHARP DS, OSTERLOH J, BECKER CE, SMITH AH, HOLMAN BL, FISHER JM: Blood pressure and blood lead concentration in bus drivers. Environ Health Prospect 78:131-137, 1988
2. SHARP DS, BECKER CE, SMITH AH: Chronic low-lead exposure: Its role in the pathogenesis of hypertension. Med Toxicol 2:210-231, 1987
3. HARLAN WR: The relationship of blood lead levels to blood pressure in the US population. Environ Health Perspect 78:9-13, 1988
4. KHALIL-MANESH F, GONICK HC, WEILER EWJ, PRINS B, WEBER MA, PURDY RE, REN Q: Effect of chelation treatment with dimercaptosuccinic acid (DMSA) on lead-related blood pressure changes. Environ Res 65:86-99, 1994
5. KHALIL-MANESH F, GONICK HC, WEILER EWJ, PRINS B, WEBER MA, PURDY RE: Lead-induced hypertension: Possible role of endothelial factors. Am J Hypertens 6:723-729, 1993
6. GONICK HC, DING Y, Ni Z, OVEISI F, VAZIRI ND: Lead-induced hypertension is related to accumulation of reactive oxygen species. ( abstract ) Am J Hypertens 9:39A, 1996
7. 2 and thromboxane induced vaso- and broncho-constriction in rat perfused lung. J Appl Physiol 71:1309-1334, 1991
8. LIN PJ, PEARSON PJ, CARTIER R, SCHAFF HV: Superoxide anion mediates the endothelium-dependent contractions to serotonin by regenerated endothelium. Thorac Cardiovasc Surg 102:378-385, 1991
9. TESFAMARIAM B, COHEN RA: Role of Superoxide anion and endothelium in vasoconstrictor action of prostaglandin endoperoxide. Am J Physiol 262:H1915-H1919, 1992
10. LUSCHER TF: Imbalance between endothelium-derived relaxing and contracting factors: A new concept in hypertension. Am J Hypertens 3:317-336, 1990
11. RUBANYI GM, VANHOUTTE PM: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250: H822-H827, 1986
12. GRYGLEWSKI RJ, PALMER RMJ, MONCADA S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454-456, 1986
13. MCCALL TB, BOUGHTON-SMITH NK, PALMER RMJ: Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with Superoxide anion. Biochem J 261:293-296, 1992
14. MYERS SI, HERNANDEZ R, CASTANEDA A: Possible role for oxygen free radicals in the regulation of renal nitric oxide synthesis and blood flow. Am J Surgery 169:604-608, 1995
15. 1) cell injury. Am J Physiol 268:F30-F38, 1995
16. SHERIDAN AM, FITZPATRICK S, WANG C, WHEELER DC, LIEBERTHAL W: Lipid peroxidation contributes to hydrogen peroxide induced cytotoxicity in renal epithelial cells. Kidney Int 49:88-93, 1996
17. 2-isoprostane production and cytolysis in renal tubular epithelial cells. J Am Soc Nephrol 6:1300-1303, 1995
18. 2 receptors. J Clin Invest 90:136-141, 1992
19. BRAMAN RS, HENDRIX SA: Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal Chem 61:2715-2718, 1989
20. WONG SHY, KNIGHT JA, HOPFER SM, ZAHARIA O, LEACH CN, SUNDERMAN FW JR: Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clim Chem 33:214-220, 1987
21. MORTON JJ, BEATTIE EC, SPEIR A, GULLIVER F: Persistent hypertension following inhibition of nitric oxide formation in young Wistar rats: Role of renin and vascular hypertrophy. J Hypertens 11:1083-1088, 1993
22. LANGENSTROER P, PIEPER GM: Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol 263:H257-H265, 1992
23. HATTORI Y, KAWASAKI H, ABE D, KANNO M: Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261:H1086-H1094, 1961
24. DING Y, VAZIRI ND, GONICK HC: Lead-induced hypertension. III. Response to sequential infusions of the reactive oxygen species scavengers, Superoxide dismutase, catalase and dimethylthiourea. (manuscript submitted)
25. BRAUHLER JM: Inhibition of synaptosomal GABA uptake by lipid peroxidation: Protection by glucocorticoids. J Neurochem 44:1282-1288, 1985
26. KALRA J, MANTHA SV, KUMAR P, PRASAD K: Protective effects of lazaroids against oxygen-free radicals induced lysosomal damage. Mol Cell Biochem 136:125-129, 1994
27. BRAUHLER JM, PREGEZER JF, CHASE RL, DUNCAN LA, JACOBSON EJ, MCCALL JM: Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 262:10438-10440, 1987
28. HALL ED, MCCALL JM, MEAN DE: Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 28:221-268, 1994
29. SHOSKES DA, XIE Y, GONZALES-CADAVID NF: Nitric oxide synthase activity in renal ischemia-reperfusion injury in the rat. Transplantation 63:495-500, 1997